Charles Winter
Chief Tech/Sci/R&D Officer at JANUX THERAPEUTICS, INC.
Net worth: 2 M $ as of 2024-04-29
Charles Winter active positions
Companies | Position | Start | End |
---|---|---|---|
JANUX THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2020-12-31 | - |
Career history of Charles Winter
Former positions of Charles Winter
Companies | Position | Start | End |
---|---|---|---|
JHL BIOTECH, INC. | Chief Tech/Sci/R&D Officer | 2015-06-30 | 2016-07-31 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | 2011-08-31 | 2015-05-31 |
Training of Charles Winter
University of Wisconsin | Undergraduate Degree |
Statistics
International
United States | 4 |
Taiwan | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
JANUX THERAPEUTICS, INC. | Health Technology |
Private companies | 1 |
---|---|
Eden Biologics, Inc.
Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
- Stock Market
- Insiders
- Charles Winter
- Experience